Blue Jet Healthcare Limited - Asset Resilience Ratio

Latest as of March 2026: 13.81%

Blue Jet Healthcare Limited (BLUEJET) has an Asset Resilience Ratio of 13.81% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Blue Jet Healthcare Limited leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.

Liquid Assets

Rs2.27 Billion

≈ $24.52 Million USD Cash + Short-term Investments

Total Assets

Rs16.41 Billion

≈ $177.49 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2020–2026)

This chart shows how Blue Jet Healthcare Limited's Asset Resilience Ratio has changed over time. See Blue Jet Healthcare Limited net asset quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Blue Jet Healthcare Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see BLUEJET stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs2.27 Billion	13.81%
Total Liquid Assets	Rs2.27 Billion	13.81%

Asset Resilience Insights

Moderate Liquidity: Blue Jet Healthcare Limited has 13.81% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Blue Jet Healthcare Limited Industry Peers by Asset Resilience Ratio

Compare Blue Jet Healthcare Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	10.93%
Ascendis Pharma AS F:A71	Biotechnology	0.00%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Chongqing Zhifei Bio Products SHE:300122	Biotechnology	-0.08%
Camurus AB ST:CAMX	Biotechnology	78.61%
Zealand Pharma A/S CO:ZEAL	Biotechnology	63.98%
Disc Medicine Inc. NASDAQ:IRON	Biotechnology	85.48%
Bicara Therapeutics Inc. Common Stock NASDAQ:BCAX	Biotechnology	39.07%

Annual Asset Resilience Ratio for Blue Jet Healthcare Limited (2020–2026)

The table below shows the annual Asset Resilience Ratio data for Blue Jet Healthcare Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2026-03-31	13.81%	Rs2.27 Billion ≈ $24.52 Million	Rs16.41 Billion ≈ $177.49 Million	+0.64pp
2025-03-31	13.17%	Rs1.87 Billion ≈ $20.19 Million	Rs14.18 Billion ≈ $153.30 Million	-13.20pp
2024-03-31	26.37%	Rs2.79 Billion ≈ $30.20 Million	Rs10.59 Billion ≈ $114.51 Million	+4.39pp
2023-03-31	21.98%	Rs1.89 Billion ≈ $20.49 Million	Rs8.62 Billion ≈ $93.23 Million	+7.11pp
2022-03-31	14.87%	Rs1.06 Billion ≈ $11.47 Million	Rs7.13 Billion ≈ $77.15 Million	+6.26pp
2021-03-31	8.61%	Rs461.64 Million ≈ $4.99 Million	Rs5.36 Billion ≈ $58.00 Million	+8.58pp
2020-03-31	0.03%	Rs1.10 Million ≈ $11.90K	Rs3.75 Billion ≈ $40.60 Million	--

pp = percentage points

About Blue Jet Healthcare Limited

NSE:BLUEJET India Biotechnology

Market Cap

$961.43 Million

Rs88.90 Billion INR

Market Cap Rank

#9215 Global

#439 in India

Share Price

Rs512.50

Change (1 day)

+2.82%

52-Week Range

Rs327.25 - Rs1010.20

All Time High

Rs1010.20